Philadelphia, PA, September 30, 2024 — Greenberg Regenerative Medicine is proud to be approaching the 2 year anniversary of successfully implementing Very Small Embryonic-Like (VSEL) stem cell therapy into their vast repertoire of regenerative medicine treatments.
Since introducing VSEL therapy, Dr. Scott Greenberg and his team have integrated this revolutionary therapy into treatment plans for patients at their Bryn Mawr, Pennsylvania office to help treat a wide range of conditions, with exceptional results.
VSEL therapy harnesses the power of naturally occurring pluripotent stem cells, which possess the ability to regenerate damaged tissues and promote the body’s self-healing processes. Pluripotent means they can become any other tissue in the body, making them extremely versatile and effective in the ailments they can treat.
The biggest advantage VSEL stem cells have over other types of stem cells is their very small size. This allows VSEL stem cells to pass through areas like the lung and blood brain barriers in the body, while larger stem cells get stuck in the lungs and don’t have a chance to reach the target areas and help the body.
“With VSELs we are seeing dramatic improvements in health in our patients with a variety of conditions and seeing increased vitality as well,” said Dr. Greenberg.
Greenberg Regenerative Medicine continues to lead the way in regenerative medicine in the Philadelphia area, offering the most advanced, personalized regenerative medicine treatments on the market today. VSEL therapy has become a cornerstone of Greenberg Regenerative Medicine’s approach, helping patients experience faster recovery times, and improved overall vitality.